Phillips 66 vs 22nd Century Group Inc — how do they compare? Phillips 66 trades at $278.18 (market cap $112.36B), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: Phillips 66 is far larger — about 180739× 22nd Century Group Inc's market cap, and Phillips 66 pays a 1.8% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Phillips 66 for 62 Days and 22nd Century Group Inc for 32 Days on average.
| PSX | XXII | |
|---|---|---|
Market Cap | $112.36B | $621.67K |
Volume | 2,374,751 | 45,625 |
Sector | Energy | Consumer Staples |
52-Week High | $281.60 | $483.00 |
52-Week Low | $126.76 | $0.80 |
Typical Hold Time | 62 Days | 32 Days |
Enterprise Value | $128.83B | -$3.69M |
Dividend Yield | 1.8% | — |
Signals from Pluang's Aura AI — not financial advice
Phillips 66 (PSX) trades at $281.60, up 3.67% with strong technical momentum as it approaches resistance at $284. The stock shows robust fundamentals with three consecutive earnings beats and improving cash flow projections for 2026. Recent news highlights structural refining advantages and AI implementation for operational efficiency, supporting the bullish analyst consensus.
PSX offers attractive valuation with P/E of 16.07 and P/S of 0.75, coupled with strong profitability metrics including 24.02% ROE. Key risks include commodity price volatility and potential policy impacts on diesel exports. With 54% analyst buy ratings and $279 consensus target, the stock presents growth potential despite near-term overbought technical conditions.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Phillips 66 is an independent refiner with 12 refineries that have a total crude throughput capacity of 2.0 million barrels per day, or mmb/d, after converting its 255 mb/d Alliance refinery to a terminal. The midstream segment comprises extensive transportation and NGL processing assets. It also includes its DCP Midstream joint venture, which holds 45 natural gas processing facilities, 11 NGL fractionation plants, and a natural gas pipeline system with 58,000 miles of pipeline. Its CPChem chemical joint venture operates facilities in the United States and the Middle East and primarily produces olefins and polyolefins.
Read more on PSX →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →